Bipolar Disorder Linked To Mitochondrial Dysfunction In Brain Cells
Researchers from the RIKEN Brain Science Institute, Japan, say there is good evidence of a link between bipolar disorder and mitochondrial dysfunction in brain nerve cells. You can read about this study in Molecular Psychiatry.Nobody is yet sure about the
http://www.medicalnewstoday.com/healthnews.php?newsid=41906&nfid=crss

Physiological Markers For Cutting, Other Self-harming Behaviors By Teenage Girls Found
Non-fatal, self-inflicted injuries by adolescent and young adult females are major public health problems and researchers have found physiological evidence that this behavior may lead to a more serious psychological condition called borderline personality
http://www.medicalnewstoday.com/medicalnews.php?newsid=45436&nfid=crss

Seroquel Study Gives Hope For Beating Depression In Bipolar Disorder
Keeping the manic-depressive illness Bipolar Disorder under control may become simpler in future if psychiatrists implement new research findings from the BOLDER II study presented during the American Psychiatry Association's 159th annual meeting 20-25 Ma
http://www.medicalnewstoday.com/medicalnews.php?newsid=44502&nfid=crss

Study Identifies Predictors Of Bipolar Disorder Risk
A new study presented today at the159th Annual Scientific Meeting of the American Psychiatric Association(APA) in Toronto, Canada identified five predictors for bipolar disorderrisk in patients who have been unsuccessfully treated with antidepressants. [c
http://www.medicalnewstoday.com/medicalnews.php?newsid=43824&nfid=crss

ABILIFY® (aripiprazole) Effictive As Maintenance Therapy In Adults With Bipolar I Disorder Following
Maintenance therapy with the Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. [click link for full article]
http://www.medicalnewstoday.com/medicalnews.php?newsid=43773&nfid=crss

Cyberonics Announces Patient Enrollment In New TRD Dosing Study
Cyberonics, Inc. (Nasdaq: CYBX) today announced that the first nine patients have been enrolled in a year-long Vagus Nerve Stimulation (VNS) Therapy dosing study that will examine treatment outcomes for patients with treatment-resistant depression (TRD) w
http://www.medicalnewstoday.com/medicalnews.php?newsid=43607&nfid=crss

The American Academy Of Child And Adolescent Psychiatry Applauds Representative Kennedy
The American Academy of Child and Adolescent Psychiatry (AACAP) applauds Representative Patrick Kennedy for his courage in speaking openly about his recent struggles with substance use and bipolar illness. For many years, Representative Kennedy has been a
http://www.medicalnewstoday.com/medicalnews.php?newsid=43367&nfid=crss

Mechanism Of Lithium Action For The Treatment Of Bipolar Disorder
Calcium is a common intracellular signaling molecule with a wide range of functions in the brain, and the regulation as well as dysregulation of calcium signaling via the principal intracellular calcium release channel, InsP3R1, has been linked to many no
http://www.medicalnewstoday.com/medicalnews.php?newsid=43317&nfid=crss

For Patients With Bipolar Disorder - Getting More From Your Doctor's Appointment
Today patients are increasingly frustrated with the brevity of scheduled appointments with their doctors. Many physicians are constrained by outside factors, such as too few practitioners, too many patients, or restrictions from health insurance companies
http://www.medicalnewstoday.com/medicalnews.php?newsid=42660&nfid=crss

Patients With Bipolar Disorder May Benefit From Less Sugar
According to an article in the Spring 2006 issue of bp Magazine, a decrease in the amount of sugar you consume may actually sweeten your mood! The article reports that a 2002 study, published in Depression and Anxiety, has shown that countries with a hig
http://www.medicalnewstoday.com/medicalnews.php?newsid=42659&nfid=crss

Light Therapy And Fluoxetine Are Equally Effective SAD (Winter Depression)
Bright artificial light and the antidepressant fluoxetine are both effective treatments for the winter form of seasonal affective disorder (SAD). A head-to-head comparison conducted in four Canadian cities over three winters is reported in an article in t
http://www.medicalnewstoday.com/medicalnews.php?newsid=42545&nfid=crss

Locked Door Psychiatric Units Have More Disadvantages Than Advantages Say Staff
The disadvantages of locking the front doors of psychiatric units outnumber the advantages by more than two to one, according to a study published in the latest Journal of Clinical Nursing.Researchers from Uppsala University in Sweden interviewed 40 menta
http://www.medicalnewstoday.com/medicalnews.php?newsid=42196&nfid=crss

Alexza Initiates AZ-002 Phase IIa Clinical Trial In Patients With Panic Disorder
AlexzaPharmaceuticals, Inc. (Nasdaq: ALXA) announced today that it has initiateda Phase IIa clinical trial with AZ-002 (Staccato(TM) alprazolam) inpatients with panic disorder. AZ-002 is an inhalation product candidatebeing developed for the acute treatme
http://www.medicalnewstoday.com/medicalnews.php?newsid=41997&nfid=crss

Highlights From The Journal Of Neuroscience
1. Wiring up for ColorPatricia R. Jusuf, Paul R. Martin, and Ulrike GrunertThe primate midget-parvocellular (PC) visual system contributes to red-green color detection. In this week's Journal, Jusuf et al. sought to determine whether selective wiring of t
http://www.medicalnewstoday.com/medicalnews.php?newsid=41480&nfid=crss

The Corporate Sponsored Creation Of Disease Turns Healthy People Into Patients, Wastes Precious Reso
The corporate sponsored creation of disease--"disease mongering"--turns healthy people into patients, wastes precious resources, and causes iatrogenic harm, say the guest editors of a special issue of PLoS Medicine devoted to how drug companies sell sickn
http://www.medicalnewstoday.com/medicalnews.php?newsid=41416&nfid=crss

Emergency Departments Are The First Stop For Millions Of Hospital Patients, USA
More than half (55 percent) of the 29.3 million admissions to U.S. community hospitals for conditions other than pregnancy, childbirth and neonatal care begin in the hospital emergency department (ED), according to HHS' Agency for Healthcare Research and
http://www.medicalnewstoday.com/medicalnews.php?newsid=41050&nfid=crss

New Dosages Of RISPERDAL® (Risperidone) Now Available
Physicians treating people with schizophrenia or bipolar mania now have expanded treatment options: Two additional dosages (3 mg and 4 mg) of RISPERDAL® M-TAB®, the fast-dissolving form of one of the most prescribed antipsychotic medications, RISPERDAL® (
http://www.medicalnewstoday.com/medicalnews.php?newsid=40274&nfid=crss

Repligen Initiates Phase 2 Clinical Trial Of RG2417 For Bipolar Depression
Repligen Corporation(Nasdaq: RGEN) today announced that the Company has initiated a Phase 2clinical trial of RG2417, an oral formulation of uridine, in patients withbipolar depression. This Phase 2 study is a multi-center, dose escalatingstudy in which 8
http://www.medicalnewstoday.com/medicalnews.php?newsid=39227&nfid=crss

Light Shed On Bipolar Disorder By Clock Molecule's Sensitivity To Lithium
Researchers at the University of Pennsylvania School of Medicine discovered that a key receptor protein is a critical component of the internal molecular clock in mammals. What's more, this molecule -called Rev-erb- is sensitive to lithium and may help sh
http://www.medicalnewstoday.com/medicalnews.php?newsid=37975&nfid=crss

Bipolar Disorder In Children And Teens, Landmark Study Released
Children and teen-agers with bipolar disorder suffer from the illness differently than adults do. Their symptoms last longer and swing more swiftly from hyperactivity and recklessness to lethargy and depression.This is the first major finding published fr
http://www.medicalnewstoday.com/medicalnews.php?newsid=37862&nfid=crss